Sri Lanka's first insulin plant to produce in 2027 — six years after its foundation stone
Minister Nalinda Jayatissa says the Koggala plant will start output in 2027. Daily FT reported its foundation stone laid in September 2020.
Minister Nalinda Jayatissa says the Koggala plant will start output in 2027. Daily FT reported its foundation stone laid in September 2020.
2026 Nobel Prize Chemistry awarded for single-handed molecule synthesis breakthrough.
Price caps on 13 essential medicines produced estimated Rs. 5.7bn saving for state under NMRA regulations.
NMRA setting maximum prices on 6,000 medicines, benchmarking against India and Bangladesh retail costs.
The Sri Lankan drug manufacturer says it shipped its first consignment to Cambodia on August 14, with Vietnam and the Philippines next on its export list.
Health Minister Nalinda Jayatissa says NMRA will consider a 6-7% drug price revision on June 30 as the rupee has fallen around 8% in six months.
NMRA Chairman Dr. Ananda Wijewickrama says revisions are underway for around 60 categories of gazetted drugs, with imported and local medicines likely to rise.
EDB Chairman Wijesinghe says current pharmaceutical export earnings are under USD 6 million; certification gap with foreign regulators is the chief constraint.
The WHO has begun a week-long mission to help Sri Lanka draft a national action plan against substandard, falsified and unregistered medical products.
Rupee depreciation and frozen drug price caps are squeezing pharma importers; Health Minister Jayatissa says a ceiling-price revision is under review.
Sri Lanka's Cabinet approved a USD 225,000 contract with Reliance Life Sciences for 6,000 pre-filled Adalimumab syringes used to treat autoimmune conditions.
The SLCPI says import licence delays, Hormuz-linked freight costs, and rupee pressure threaten essential medicine supply, calling for urgent state action.